This article is more than 5 years old. Information may no longer be current.
ASH elects four to executive committee
Click Here to Manage Email Alerts
ASH elected four new members to its executive committee.
Roy L. Silverstein, MD, chairman of the department of medicine at Medical College of Wisconsin, will serve a 1-year term as vice president, followed by successive terms as president-elect and president. Silverstein also is associate director for the college’s cancer center, as well as senior investigator for the Blood Research Institute at BloodCenter of Wisconsin.
Robert A. Brodsky, MD, professor of medicine and oncology and director of the division of hematology at Johns Hopkins School of Medicine, will serve a 4-year term as secretary. Brodsky also is director of the T32 training program in hematology and director of the physician–scientist pathway for the Osler Residency Program at Johns Hopkins.
John C. Byrd, MD, and Cynthia E. Dunbar, MD, each will serve 4-year terms as councilors.
Byrd, a HEMONC TODAY Editorial Board member, is chair of leukemia research and director of the division of hematology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Dunbar is section head and senior investigator for the hematology branch in the division of intramural research at the NHLBI.
“Hematologists are at the forefront of cutting-edge advancements in science and patient care, and as the premier professional society for the field, ASH plays an important role in providing high-quality training, education and research,” 2016 ASH President Charles S. Abrams, MD, of University of Pennsylvania, said in a press release. “All of these attributes require support and strong leadership to develop and grow.
“Drs. Silverstein, Brodsky, Byrd and Dunbar have demonstrated impressive commitment to hematology and to the society through their years of service as editors, program leaders, and mentors,” Abrams added. “These experiences, coupled with their breadth of knowledge in hematology, will shape the future of the field.”